Vaccines for women to prevent neonatal tetanus

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 5, 2013, Pages

  Demicheli, Vittorio ^a   Barale, Antonella ^b   Rivetti, Alessandro ^a  

^a Azienda Sanitaria Locale ASL AL   (Italy)

^b ASL VC   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; DIPHTHERIA TETANUS TOXOID; INFLUENZA VACCINE; TETANUS TOXOID;

CAUSE OF DEATH; DRUG EFFICACY; FEMALE; HUMAN; NEWBORN DEATH; NEWBORN MORTALITY; NEWBORN TETANUS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ADULT; META ANALYSIS; MORTALITY; NEWBORN; TETANUS;

ADULT; CAUSE OF DEATH; FEMALE; HUMANS; INFANT, NEWBORN; INFLUENZA VACCINES; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TETANUS; TETANUS TOXOID;

EID: 84891697834     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002959.pub3     Document Type: Review

References (60)

1. Black RE, Huber DH, Curlin GT. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bulletin of the World Health Organization 1980;58(6):927-30.
2. Newell KW, Duenas Lehmann A, LeBlanc DR, Garces Osorio N. The use of toxoid for the prevention of tetanus neonatorum: preliminary report of a double-blind controlled field trial. Bulletin of the World Health Organization 1964;30:439-44.
3. Newell KW, Duenas Lehmann A, LeBlanc DR, Garces Osorio N. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bulletin of the World Health Organization 1966;35(6):863-71.
4. Abuwa PN, Alikor EA, Gbaraba PV, Mung KS, Oruamabo RS. Epidemiology of neonatal tetanus in the Rivers State of Nigeria: a community based study. Journal of Epidemiology and Community Health. 1997;51(3):336.
5. Al-Safi ZA, Shavell VI, Gonik B. Vaccination in pregnancy. Womens Health (Lond Engl) 2011;7(1):109-19.
6. Anh NQ, Hong HA, Nhon TN, Thinh ND, Van NT, Hendriks J. Tetanus antibodies measured by the toxin binding inhibition test (ToBI) in mothers and children in the Neonatal Tetanus Program in Vietnam. Developments in Biological Standardization 1999;101:247-53.
7. Axelsson I. A Cochrane review on the umbilical cord care and prevention of infections. Antiseptic solutions are not necessary in developed countries but life-saving in developing countries [Cochrane-oversikt om att forebygga navelinfektioner. Antiseptisk losning ar onodig i i-lander men livraddande i u-lander.]. Lakartidningen 2002;99(14):1563-6.
8. Aylward RB, Mansour E, Oonel-S A, Tawfik SA, Makar S, Abu el Kheir A, et al.The role of surveillance in a 'high risk' approach to the elimination of neonatal tetanus in Egypt. International Journal of Epidemiology 1996;25(6):1286-91.
9. Baltazar JC, Sarol JN Jr. Prenatal tetanus immunization and other practices associated with neonatal tetanus. Southeast Asian Journal of Tropical Medicine and Public Health 1994;25(1):132-8.
10. Basher MS. Knowledge and practice about TT vaccination among undergraduate female medical students. Mymensingh Medical Journal 2010;19(4):520-3.
11. Berggren WL, Berggren GM. Changing incidence of fatal tetanus of the newborn. A retrospective study in a defined rural Haitian populations. American Journal of Tropical Medicine And Hygiene 1971;20(3):491-4.
12. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. International Journal of Epidemiology 2010;39(Suppl 1):i102-9.
13. Canning D, Razzaque A, Driessen J, Walker DG, Streatfield PK, Yunus M. The effect of maternal tetanus immunization on children's schooling attainment in Matlab, Bangladesh: follow-up of a randomized trial. Social Science & Medicine 2011;72(9):1429-36.
14. Chai F, Prevots DR, Wang X, Birmingham M, Zhang R, Chai F. Neonatal tetanus incidence in China, 1996-2001, and risk factors for neonatal tetanus, Guangxi Province, China. International Journal of Epidemiology 2004;33(3):551-7.
15. Chongsuvivatwong V, Bujakorn L, Kanpoy V, Treetrong R. Control of neonatal tetanus in southern Thailand. International Journal of Epidemiology 1993;22(5):931-5.
16. de Walque D. Do unsafe tetanus toxoid injections play a significant role in the transmission of HIV/AIDS? Evidence from seven African countries. Sexually Transmitted Infections 2008;84(2):122-5.
17. Dhillon H, Menon PS. Active immunization of women in pregnancy with two injections of adsorbed tetanus toxoid for prevention of tetanus neonatorum in Punjab, India. Indian Journal of Medical Research 1975;63(4):583-9.
18. Dietz V, Milstien JB, van Loon F, Cochi S, Bennett J. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bulletin of the World Health Organization 1996;74(6):619-28.
19. Gupta SD, Keyl PM. Effectiveness of prenatal tetanus toxoid immunization against neonatal tetanus in a rural area in India. Pediatric Infectious Disease Journal 1998;17(4):316-21.
20. Halperin BA, Morris A, Mackinnon-Cameron D, Mutch J, Langley JM, McNeil SA, et al.Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clinical Infectious Diseases 2011;53(9):885-92.
21. Hardegree MC, Barile MF, Pittman M, Schofield FD, Maclennan R, Kelly A. Immunization against neonatal tetanus in New Guinea. Bulletin of the World Health Organization 1970;43(3):439-51.
22. Hasnain S, Sheikh NH. Causes of low tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan. Eastern Mediterranean Health Journal 2007;13(5):1142-52.
23. Heredia AF, Borkar MB, Rao SS. Active immunization in pregnancy with fluid tetanus toxoid. Indian Journal of Medical Sciences 1968;22(4):209-13.
24. Hlady WG, Bennett JV, Samadi AR, Begum J, Hafez A, Tarafdar AI, et al.Neonatal tetanus in rural Bangladesh: risk factors and toxoid efficacy. American Journal of Public Health 1992;82(10):1365-9.
25. Kielmann AA, Vohra SR. Control of tetanus neonatorum in rural communities--immunization effects of high-dose calcium phosphate-absorbed tetanus toxoid. Indian Journal of Medical Research 1977;66(6):906-16.
26. Koenig MA, Roy NC, McElrath T, Shahidullah M, Wojtyniak B. Duration of protective immunity conferred by maternal tetanus toxoid immunization: further evidence from Matlab, Bangladesh. American Journal of Public Health 1998;88(6):903-7.
27. Lassi ZS, Haider BA, Bhutta ZA. Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD007754.pub2]
28. MacLennan R, Schofield FD, Pittman M, Hardegree MC, Barile MF. Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids. Bulletin of the World Health Organization 1965;32(5):683-97.
29. Mulholland K, Suara RO, Siber G, Roberton D, Jaffar S, N'Jie J, et al.Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in the Gambia. JAMA 1996;275(15):1182-8.
30. Nohynek H, Gustafsson L, Capeding MR, Kayhty H, Olander RM, Pascualk L, et al.Effect of transplacentally acquired tetanus antibodies on the antibody responses to haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants. Pediatric Infectious Disease Journal 1999;18(1):25-30.
31. Orozova-Bekkevold I, Jensen H, Stensballe L, Olsen J. Maternal vaccination and preterm birth: using data mining as a screening tool. Pharmacy World and Science 2007;29(3):205-12.
32. Perry H, Weierbach R, Hossain I, Islam R. Tetanus toxoid immunization coverage among women in zone 3 of Dhaka city: the challenge of reaching all women of reproductive age in urban Bangladesh. Bulletin of the World Health Organization 1998;76(5):449-57.
33. Rahman M, Chen LC, Chakraborty J, Yunus M, Chowdhury AI, Sarder AM, et al.Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh. Bulletin of the World Health Organization 1982;60(2):261-7.
34. Rahman M, Chen LC, Chakraborty J, Yunus M, Faruque AS, Chowdhury AI. Use of tetanus toxoid for the prevention of neonatal tetanus. 2. Immunization acceptance among pregnant women in rural Bangladesh. Bulletin of the World Health Organization 1982;60(2):269-77.
35. Relyveld E, Bengounia A, Huet M, Kreeftenberg JG. Antibody response of pregnant women to two different absorbed tetanus toxoids. Vaccine 1991;9(5):369-72.
36. Salama MM, Hady OA, Ashour W, Mostafa A, El Alkamy S, El Sayed N, et al.A randomized controlled trial of oral administration of tetanus toxoid (TT) versus tetanus and reduced diphtheria (Td) in pregnant women. Journal of Clinical Immunology 2009;29(4):524-31.
37. Schofield FD, Tucker VM, Westbrook GR. Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy. BMJ 1961;5255:785-9.
38. Silveira CM, Caceres VM, Dutra MG, Lopes-Camelo J, Castilla EE. Safety of tetanus toxoid in pregnant women: a hospital-based case-control study of congenital anomalies. Bulletin of the World Health Organization 1995;73(5):605-8.
39. Stanfield JP, Gall D, Bracken PM. Single-dose antenatal tetanus immunisation. Lancet 1973;1(7797):215-9.
40. Suri JC, Dhillon H, Grewal HS. Active immunization of women in pregnancy for prevention of neonatal tetanus. Bulletin of the World Health Organization 1964;31:349-57.
41. Tall F, Prazuck T, Roisin A, Sanou J, Nacro B, Traore A, et al.Risk factors for neonatal tetanus in western Burkina Faso. Case-control study [Facteurs de risque du tetanos neonatal dans l'ouest du Burkina Faso. Etude cas temoin]. Bulletin de la Societe de Pathologie Exotique 1991;84(5 Pt 5):558-61.
42. Traverso HP, Kamil S, Rahim H, Samadi AR, Boring JR, Bennett JV. A reassessment of risk factors for neonatal tetanus. Bulletin of the World Health Organization 1991;69(5):573-9.
43. Yala PF. Prevention of neonatal tetanus by active immunization of pregnant women in Brazzaville. Practical evalation and a comparison of single-dose and triple-dose vaccinations. Bulletin de la Societe de Pathologie Exotique et de ses Fil 1980;73(1):15-22.
44. Yusuf B, Solter S, Bertsch D, Arnold RB. Impact of a tetanus toxoid immunization mass campaign on neonatal tetanus mortality in Aceh Province, Indonesia. Southeast Asian Journal of Tropical Medicine and Public Health 1991;22(3):351-6.
45. Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers' Handbook 4.2.2 [updated March 2004]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
46. Altman DG, Bland JM. Interaction revisited: the differences between two estimates. BMJ 2003;326:219.
47. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al.Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375(9730):1969-87.
48. Descombey P. L'anatoxine tetanique. Comptes rendus des séances de la Société de biologie et de ses filiales 1924;91:239-41.
49. Dietz V, Milstein JB, van Loon F, Cochi S, Bennet J. Performance and potency of tetatus toxoid: implications for eliminating neonatal tetanus. Bulletin of the World Health Organization 1996;74(6):619-28.
50. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
51. Jefferson TO, Jefferson VM. The quest for trials on the efficacy of human vaccines. Results of the handsearch of "Vaccine". Vaccine 1996;14:461-4.
52. Jefferson TO. Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration. Vaccine 1998;16:1487-95.
53. Prevots DR. Neonatal tetanus. Bulletin of the World Health Organization 1998;76 Suppl 2:135-6. [PUBMED: 10063693]
54. The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2003.
55. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
56. World Health Organization. Progress towards the global elimination of neonatal tetanus, 1990-1998. Weekly Epidemiological Record 1999;74(10):73-80.
57. World Health Organization. Tetanus vaccine. WHO position paper. Weekly Epidemiological Record 2006;81(20):198-208.
58. World Health Organization. Maternal and Neonatal Tetanus (MNT) elimination. http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index.html accessed on January 11th, 2012.
59. Demicheli V, Barale A. Vaccines for preventing neonatal tetanus. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002959]
60. Demicheli V, Barale A, Rivetti A. Vaccines for women to prevent neonatal tetanus. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD002959.pub2]